159 related articles for article (PubMed ID: 17373550)
1. Leishmania amazonensis trypanothione reductase: evaluation of the effect of glutathione analogs on parasite growth, infectivity and enzyme activity.
Castro-Pinto DB; Lima EL; Cunha AS; Genestra M; De Léo RM; Monteiro F; Leon LL
J Enzyme Inhib Med Chem; 2007 Feb; 22(1):71-5. PubMed ID: 17373550
[TBL] [Abstract][Full Text] [Related]
2. Glutathione and the redox control system trypanothione/trypanothione reductase are involved in the protection of Leishmania spp. against nitrosothiol-induced cytotoxicity.
Romão PR; Tovar J; Fonseca SG; Moraes RH; Cruz AK; Hothersall JS; Noronha-Dutra AA; Ferreira SH; Cunha FQ
Braz J Med Biol Res; 2006 Mar; 39(3):355-63. PubMed ID: 16501815
[TBL] [Abstract][Full Text] [Related]
3. Structure-guided approach to identify a novel class of anti-leishmaniasis diaryl sulfide compounds targeting the trypanothione metabolism.
Colotti G; Saccoliti F; Gramiccia M; Di Muccio T; Prakash J; Yadav S; Dubey VK; Vistoli G; Battista T; Mocci S; Fiorillo A; Bibi A; Madia VN; Messore A; Costi R; Di Santo R; Ilari A
Amino Acids; 2020 Feb; 52(2):247-259. PubMed ID: 31037461
[TBL] [Abstract][Full Text] [Related]
4. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
[TBL] [Abstract][Full Text] [Related]
5. Leishmania infantum trypanothione reductase is a promiscuous enzyme carrying an NADPH:O2 oxidoreductase activity shared by glutathione reductase.
Angiulli G; Lantella A; Forte E; Angelucci F; Colotti G; Ilari A; Malatesta F
Biochim Biophys Acta; 2015 Sep; 1850(9):1891-7. PubMed ID: 26033467
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the trypanothione reductase gene of Leishmania decreases its ability to survive oxidative stress in macrophages.
Dumas C; Ouellette M; Tovar J; Cunningham ML; Fairlamb AH; Tamar S; Olivier M; Papadopoulou B
EMBO J; 1997 May; 16(10):2590-8. PubMed ID: 9184206
[TBL] [Abstract][Full Text] [Related]
7. The parasite-specific trypanothione metabolism of trypanosoma and leishmania.
Krauth-Siegel RL; Meiering SK; Schmidt H
Biol Chem; 2003 Apr; 384(4):539-49. PubMed ID: 12751784
[TBL] [Abstract][Full Text] [Related]
8. Ovothiol and trypanothione as antioxidants in trypanosomatids.
Ariyanayagam MR; Fairlamb AH
Mol Biochem Parasitol; 2001 Jul; 115(2):189-98. PubMed ID: 11420105
[TBL] [Abstract][Full Text] [Related]
9. Trypanothione reductase activity is prominent in metacyclic promastigotes and axenic amastigotes of Leishmania amazonesis. Evaluation of its potential as a therapeutic target.
Castro-Pinto DB; Echevarria A; Genestra MS; Cysne-Finkelstein L; Leon LL
J Enzyme Inhib Med Chem; 2004 Feb; 19(1):57-63. PubMed ID: 15202494
[TBL] [Abstract][Full Text] [Related]
10. Cloning and expression of trypanothione reductase from a New World Leishmania species.
Castro-Pinto DB; Genestra M; Menezes GB; Waghabi M; Gonçalves A; De Nigris Del Cistia C; Sant'Anna CM; Leon LL; Mendonça-Lima L
Arch Microbiol; 2008 Apr; 189(4):375-84. PubMed ID: 18060667
[TBL] [Abstract][Full Text] [Related]
11. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.
Stoll VS; Simpson SJ; Krauth-Siegel RL; Walsh CT; Pai EF
Biochemistry; 1997 May; 36(21):6437-47. PubMed ID: 9174360
[TBL] [Abstract][Full Text] [Related]
12. Polyamine metabolism in Leishmania: from arginine to trypanothione.
Colotti G; Ilari A
Amino Acids; 2011 Feb; 40(2):269-85. PubMed ID: 20512387
[TBL] [Abstract][Full Text] [Related]
13. The synthesis and inhibitory activity of dethiotrypanothione and analogues against trypanothione reductase.
Czechowicz JA; Wilhelm AK; Spalding MD; Larson AM; Engel LK; Alberg DG
J Org Chem; 2007 May; 72(10):3689-93. PubMed ID: 17439174
[TBL] [Abstract][Full Text] [Related]
14. Metabolomic Reprogramming of C57BL/6-Macrophages during Early Infection with
Mamani-Huanca M; Muxel SM; Acuña SM; Floeter-Winter LM; Barbas C; López-Gonzálvez Á
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206906
[No Abstract] [Full Text] [Related]
15. Entamoeba histolytica lacks trypanothione metabolism.
Ariyanayagam MR; Fairlamb AH
Mol Biochem Parasitol; 1999 Sep; 103(1):61-9. PubMed ID: 10514081
[TBL] [Abstract][Full Text] [Related]
16. Thiol redox biology of trypanosomatids and potential targets for chemotherapy.
Leroux AE; Krauth-Siegel RL
Mol Biochem Parasitol; 2016; 206(1-2):67-74. PubMed ID: 26592324
[TBL] [Abstract][Full Text] [Related]
17. Identification and binding mode of a novel Leishmania Trypanothione reductase inhibitor from high throughput screening.
Turcano L; Torrente E; Missineo A; Andreini M; Gramiccia M; Di Muccio T; Genovese I; Fiorillo A; Harper S; Bresciani A; Colotti G; Ilari A
PLoS Negl Trop Dis; 2018 Nov; 12(11):e0006969. PubMed ID: 30475811
[TBL] [Abstract][Full Text] [Related]
18. Targeting Trypanothione Metabolism in Trypanosomatids.
González-Montero MC; Andrés-Rodríguez J; García-Fernández N; Pérez-Pertejo Y; Reguera RM; Balaña-Fouce R; García-Estrada C
Molecules; 2024 May; 29(10):. PubMed ID: 38792079
[TBL] [Abstract][Full Text] [Related]
19. Expression, purification, and characterization of Leishmania donovani trypanothione reductase in Escherichia coli.
Mittal MK; Misra S; Owais M; Goyal N
Protein Expr Purif; 2005 Apr; 40(2):279-86. PubMed ID: 15766869
[TBL] [Abstract][Full Text] [Related]
20. Identification of chalcone-based antileishmanial agents targeting trypanothione reductase.
Ortalli M; Ilari A; Colotti G; De Ionna I; Battista T; Bisi A; Gobbi S; Rampa A; Di Martino RMC; Gentilomi GA; Varani S; Belluti F
Eur J Med Chem; 2018 May; 152():527-541. PubMed ID: 29758517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
